Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Aspira Pathlab and Diagnostics Ltd

Your Vote -

Buy

66.67%

Hold

0.00%

Sell

33.33%

66.67%

3 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Aspira Pathlab and Diagnostics Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Aspira Pathlab & Dia posts Q3 net profit of Rs 0.38 cr

    7 Feb 2025, 7:12PM The company reported standalone net profit during the quarter stood at Rs 0.38 crore compared to net loss of Rs 0.74 crore in the previous year quarte
  • Aspira Pathlab & Dia - Integrated Filing (Financial)

    7 Feb 2025, 6:11PM Integrated Filing (Financial) for third quarter and nine months ended December 31, 2024
  • Aspira Pathlab & Dia - Board Meeting Outcome for For Unaudited Financial Results (Both Standalone & Consolidated) Alongwith L

    7 Feb 2025, 5:31PM Outcome of the Board Meeting dated February 07, 2025\r\n
  • Aspira Pathlab & Dia - Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Nine Months E

    31 Jan 2025, 1:33PM Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2025 ,inter alia, to
  • Aspira Pathlab & Dia - Reconstitution Of Audit And Stakeholder Relationship Committee W.E.F February 01, 2025

    29 Jan 2025, 1:48PM Reconstitution of Audit and Stakeholdership Relationship Committee by appointing Mr. Manas Mengar (DIN:10218206)Independent Director of the Company as
  • Aspira Pathlab & Dia - Announcement under Regulation 30 (LODR)-Resignation of Director

    22 Jan 2025, 7:16PM Resignation of Mr. Avinash Chander Mahajan (DIN:00041661) as Non-executive and Independent Director of the Company with the immediate effect.
  • Aspira Pathlab & Dia has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2024

    20 Jan 2025, 1:40PM As of December 2024, 18.55% is owned by Indian Promoters and 81.45% by Public. <p align=justify> Top four Promoters holding highest number of shares o
  • Aspira Pathlab & Dia - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    8 Jan 2025, 2:09PM Compliance Certificate in accordance with regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended Decembe
  • Aspira Pathlab & Dia - Intimation For Change In The Name Of The Registrar And Share Transfer Agent

    2 Jan 2025, 1:36PM This is to inform that the name of our Registrar and Share Transfer Agent has been changed from Link Intime India Private Limited to MUFG Intime India

Key fundamentals

Evaluate the intrinsic value of Aspira Pathlab and Diagnostics Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 11.2205 13.7122 13.6482 9.5651 10.6707
Liabilities 11.2205 13.7122 13.6482 9.5651 10.6707
Equity 10.293 10.293 10.293 10.293 9.293
Gross Profit -1.1868 1.5932 6.3731 3.5132 -1.8276
Net Profit -2.6722 -0.0887 4.4594 1.381 -4.2406
Cash From Operating Activities 1.053 -0.0121 2.031 5.6734 -1.8671
NPM(%) -20.23 -0.61 22.81 9.08 -50.38
Revenue 13.2049 14.4569 19.5419 15.2054 8.4163
Expenses 14.3917 12.8637 13.1688 11.6922 10.244
ROE(%) -51.25 -1.7 85.53 26.48 -81.33

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Aspira Pathlab and Diagnostics Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 809.25 -0.64 11.41 47.98 1321.50 1.42
Lotus Eye Hospital and Institute Ltd 58.19 1.50 237.75 174.83 14.01 0.88
Bharat Immunological and Biologicals Corporation Ltd 21.32 -1.30 0.00 363.01 -39.50 0.00
Astec Lifesciences Ltd 654.90 -5.39 0.00 164.85 -239.30 0.00

Company Info

Aspira Pathlab & Diagnostics Ltd. Was incorporated as 03td July in the year 1973 in the name of 'industrial Gas & Steel Products (India) Ltd.' It has changed its name to 'Utkal Soap Products Ltd.' on 4th February, 1980. USPL with the main object of dealing in gases Products & Steel Products, Subsequent to change of name of the Company, it has changed its object in 1980 to manufacture laundry soaps for Hindustan Lever Limited, having its factory at Sambalput - Orissa. the Company has stopped Manufacturing production since November, 2004 as the job work for Hindustan Lever Limited was not renewed because of additional duties levied by the Government, it has became unviable proposal & the Company has disposed off all its assets in 2005. The employees have been paid off their dues as per settlement with the Labour union, Since 2005.The Company has changed its object clause on 10th August, 2016 & Ventured into diagnostic centers laboratories etc, & stated generating income from December, 2016 onwards. The Company changed its name to 'Aspira Parthlab & Diagnostics Ltd.' on 16th November, 2016.

Aspira Pathlab & Diagnostics Ltd. Was incorporated as 03td July in the year 1973 in the name of 'industrial Gas & Steel Products (India) Ltd.' It has changed its name to 'Utkal Soap Products Ltd.' on 4th February, 1980. USPL with the main object of dealing in gases Products & Steel Products, Subsequent to change of name of the Company, it has changed its object in 1980 to manufacture laundry soaps for Hindustan Lever Limited, having its factory at Sambalput - Orissa. the Company has stopped Manufacturing production since November, 2004 as the job work for Hindustan Lever Limited was not renewed because of additional duties levied by the Government, it has became unviable proposal & the Company has disposed off all its assets in 2005. The employees have been paid off their dues as per settlement with the Labour union, Since 2005.The Company has changed its object clause on 10th August, 2016 & Ventured into diagnostic centers laboratories etc, & stated generating income from December, 2016 onwards. The Company changed its name to 'Aspira Parthlab & Diagnostics Ltd.' on 16th November, 2016.

Read More

Parent Organisation

Aspira Pathlab & Diagnostics Ltd.

Founded

03/07/1973

Managing Director

Dr.Pankaj J Shah

NSE Symbol

FAQ

The current price of Aspira Pathlab and Diagnostics Ltd is

The 52-week high for Aspira Pathlab and Diagnostics Ltd is

The market capitalization of Aspira Pathlab and Diagnostics Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Aspira Pathlab and Diagnostics Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Aspira Pathlab and Diagnostics Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Aspira Pathlab and Diagnostics Ltd shares.

The CEO of Aspira Pathlab and Diagnostics Ltd is Dr.Pankaj J Shah, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT